NDC 21695-665

Plavix

Clopidogrel Bisulfate

Plavix is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Rebel Distributors Corp. The primary component is Clopidogrel Bisulfate.

Product ID21695-665_1086a7b4-b89b-4bee-8120-5f752626c046
NDC21695-665
Product TypeHuman Prescription Drug
Proprietary NamePlavix
Generic NameClopidogrel Bisulfate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date1900-01-01
Marketing CategoryNDA / NDA
Application NumberNDA020839
Labeler NameRebel Distributors Corp
Substance NameCLOPIDOGREL BISULFATE
Active Ingredient Strength75 mg/1
Pharm ClassesDecreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 21695-665-90

90 TABLET, FILM COATED in 1 BOTTLE (21695-665-90)
Marketing Start Date1900-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 21695-665-90 [21695066590]

Plavix TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020839
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1900-01-01
Inactivation Date2019-09-24

NDC 21695-665-30 [21695066530]

Plavix TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA020839
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1900-01-01
Inactivation Date2019-09-24

Drug Details

Active Ingredients

IngredientStrength
CLOPIDOGREL BISULFATE75 mg/1

OpenFDA Data

SPL SET ID:1086a7b4-b89b-4bee-8120-5f752626c046
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213169
  • 309362
  • Pharmacological Class

    • Decreased Platelet Aggregation [PE]
    • P2Y12 Platelet Inhibitor [EPC]
    • P2Y12 Receptor Antagonists [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]